Concepedia

Felicia Kuperwaser

FK

Statistics

Publications

8

Citations

311

H-Index

8

Active since

2015

Affiliations

New York University(Current)

Brigham and Women's Hospital

Harvard University

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Institute for Systems Biology

Felicia Kuperwaser is an author at New York University specializing in tumor biology, medicine, and therapy resistance.

ORCID

Top concepts

Publications per year

2015–2024

8

Publications

8

Cellular adaptation to cancer therapy along a resistance continuum

Gustavo S. França, Maayan Baron, Benjamin R. King et al. · Nature · 2024 · 119 citations · Full text

, , +7

Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Amanda C. Foks, Daniel Engelbertsen, Felicia Kuperwaser et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 63 citations · Full text

Expansion of CD25 <sup>+</sup> Innate Lymphoid Cells Reduces Atherosclerosis

Daniel Engelbertsen, Amanda C. Foks, Noah Alberts‐Grill et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 47 citations · Full text

Drug-induced adaptation along a resistance continuum in cancer cells

Gustavo S. França, Maayan Baron, Maayan Pour et al. · 2022 · 23 citations · Full text

, , +20

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice

Daniel Engelbertsen, Marie A.C. Depuydt, Robin A.F. Verwilligen et al. · Journal of the American Heart Association · 2018 · 20 citations · Full text

1–5 of 8